Topical application of F991, an immunoglobulin free light chain antagonist, prevents development of contact sensitivity in mice

Background Exposure to reactive chemicals or environmental allergens can lead to hypersensitivity reactions in the skin of predisposed people. Most of these reactions are of atopic origin, but a subgroup of patients exhibits skin hypersensitivity reactions without features of atopy.

[1]  A. Kraneveld,et al.  Free immunoglobulin light chains as target in the treatment of chronic inflammatory diseases. , 2006, European journal of pharmacology.

[2]  D. Postma,et al.  Elicitation of allergic asthma by immunoglobulin free light chains. , 2005, Proceedings of the National Academy of Sciences of the United States of America.

[3]  P. Askenase,et al.  Extravascular T-cell recruitment requires initiation begun by Valpha14+ NKT cells and B-1 B cells. , 2004, Trends in immunology.

[4]  F. Redegeld,et al.  Immunoglobulin free light chains and mast cells: pivotal role in T-cell-mediated immune reactions? , 2003, Trends in immunology.

[5]  P. Askenase,et al.  Subunits of IgM Reconstitute Defective Contact Sensitivity in B-1 Cell-Deficient xid Mice: κ Light Chains Recruit T Cells Independent of Complement1 , 2002, The Journal of Immunology.

[6]  Y. Tomimori,et al.  Chymase Inhibitor Improves Dermatitis in NC/Nga Mice , 2002, International Archives of Allergy and Immunology.

[7]  C. Horikawa,et al.  Mast cell chymase regulates dermal mast cell number in mice. , 2002, Biochemical and biophysical research communications.

[8]  I. Kimber,et al.  Allergic contact dermatitis: the cellular effectors , 2002, Contact dermatitis.

[9]  M. Kool,et al.  Immunoglobulin-free light chains elicit immediate hypersensitivity-like responses , 2002, Nature Medicine.

[10]  M. Kool,et al.  Key role for mast cells in nonatopic asthma. , 2002, Journal of immunology.

[11]  C. Akdis,et al.  Epidemiology, clinical features, and immunology of the “intrinsic” (non‐IgE‐mediated) type of atopic dermatitis (constitutional dermatitis) , 2001, Allergy.

[12]  G. Kollias,et al.  Mast Cells Control Neutrophil Recruitment during T Cell–Mediated Delayed-Type Hypersensitivity Reactions through Tumor Necrosis Factor and Macrophage Inflammatory Protein 2 , 2000, The Journal of experimental medicine.

[13]  Y. Kitano,et al.  Immediate contact hypersensitivity induced by repeated hapten challenge in mice , 2000, Contact dermatitis.

[14]  K. Kawada,et al.  Immunoglobulin E production in mice by means of contact sensitization with a simple chemical, hapten. , 1997, The Journal of allergy and clinical immunology.

[15]  F. Nijkamp,et al.  Mucosal exudation associated with a pulmonary delayed-type hypersensitivity reaction in the mouse. Role for the tachykinins. , 1994, Journal of immunology.

[16]  P. Vassalli,et al.  Tumor necrosis factor is a critical mediator in hapten induced irritant and contact hypersensitivity reactions , 1991, The Journal of experimental medicine.

[17]  I. Hammel,et al.  Unequivocal delayed hypersensitivity in mast cell-deficient and beige mice. , 1984, Science.

[18]  H. van Loveren,et al.  Defective elicitation of delayed-type hypersensitivity in W/Wv and SI/SId mast cell-deficient mice. , 1983, Journal of immunology.

[19]  H. van Loveren,et al.  An early component of delayed-type hypersensitivity mediated by T cells and mast cells , 1983, The Journal of experimental medicine.

[20]  R. Bluestone,et al.  Free immunoglobulin light chains in connective tissue diseases. , 1968, Annals of the rheumatic diseases.